Carotenuto, Antonio IN VIVO ASSESSMENT OF GLYMPHATIC SYSTEM IN MULTIPLE SCLEROSIS. [Tesi di dottorato]
|
Testo
Carotenuto_Antonio_34.pdf Download (17MB) |
| Tipologia del documento: | Tesi di dottorato |
|---|---|
| Lingua: | English |
| Titolo: | IN VIVO ASSESSMENT OF GLYMPHATIC SYSTEM IN MULTIPLE SCLEROSIS |
| Autori: | Autore Email Carotenuto, Antonio antonio.carotenuto@unina.it |
| Numero di pagine: | 40 |
| Istituzione: | Università degli Studi di Napoli Federico II |
| Dipartimento: | Neuroscienze e Scienze Riproduttive ed Odontostomatologiche |
| Dottorato: | Neuroscienze |
| Ciclo di dottorato: | 34 |
| Coordinatore del Corso di dottorato: | nome email Taglialatela, Maurizio maurizio.taglialatela@unina.it |
| Tutor: | nome email Brescia Morra, Vincenzo [non definito] Rocca, Maria Assunta [non definito] |
| Numero di pagine: | 40 |
| Parole chiave: | Multiple sclerosis; glymphatic system; pathology; neurodegeneration; progression. |
| Settori scientifico-disciplinari del MIUR: | Area 06 - Scienze mediche > MED/26 - Neurologia Area 06 - Scienze mediche > MED/37 - Neuroradiologia |
| Depositato il: | 10 Ago 2026 19:50 |
| Ultima modifica: | 02 Set 2026 21:10 |
| URI: | https://www.fedoa.unina.it/id/eprint/17135 |
Abstract
BACKGROUND. Glymphatic system acts as a brain waste cleaner, avoiding the accumulation of proinflammatory and toxic molecules. Impaired glymphatic functioning may contribute to MS pathology. However, studies evaluating glymphatic system in MS are lacking. OBJECTIVE. To assess glymphatic function in multiple sclerosis (MS) and to evaluate the association between glymphatic function, clinical disability, disease course, white (WM) and gray matter (GM) lesions and atrophy and WM microstructural damage. DESIGN/METHODS. We enrolled 71 MS patients (49 relapsing-remitting [RR]; 22 progressive [P]MS) and 32 matched healthy controls (HCs). Each subject underwent neurological and MRI assessment including T1 and T2 imaging, diffusion- and susceptibility weighted imaging and double inversion recovery. Glymphatic function was measured through the diffusion along perivascular space index (DTI-ALPS) by manually drawing regions of interest on brain areas where veins and paravascular spaces run perpendicular to lateral ventricles and fibres axis. RESULTS. MS patients showed lower DTI-ALPS vs HCs (estimated mean difference [EMD]: -0.09, p=0.01). RRMS and PMS patients displayed lower DTI-ALPS (EMD: -0.06, p=0.04 and EMD: -0.19, p=0.001, respectively) vs HCs with PMS showing lower DTI-ALPS vs RRMS (EMD: -0.09, p=0.03). Lower DTI-ALPS correlated with more severe clinical disability (r=-0.45, p=0.001) and longer disease duration (r=-0.37, p=0.004). DTI-ALPS progressively reduced over the first 4.13 years of disease course (r=-0.38, p=0.04) without further worsening thereafter. Lower DTI-ALPS was associated with cortical and deep GM atrophy (r=0.30, p=0.02 and r=0.42, p=0.003, respectively), reduced fractional anisotropy and increased mean diffusivity in normal-appearing WM (r=0.45, p=0.001 and r=-0.45, p=0.001) and higher WM and cortical lesion volume (r=-0.36, p=0.006). CONCLUSIONS. Glymphatic system is impaired in MS, especially in PMS. Impaired glymphatic function correlated with more severe disability and MS-related MRI pathological processes reflecting both neurodegeneration and neuroinflammation. Therefore, glymphatic impairment may fuel MS pathological processes resulting in clinical disability.
Downloads
Downloads per month over past year
Actions (login required)
![]() |
Modifica documento |


